MedTrace Logo

Use of a Lifeline Graft in the A-V Shunt Model

NCT00850252 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL

Last updated 2013-07-17

No results posted yet for this study

Summary

This study will assess the safety and efficacy of a completely autologous and completely biological tissue engineered blood vessel (TEBV) called Lifeline™ used as an arteriovenous fistula for dialysis access.

Conditions

  • ESRD
  • Hemodialysis

Interventions

DEVICE

Lifeline

Surgical arteriovenous fistula formation with the use of Lifeline blood vessel

Sponsors & Collaborators

  • Cytograft Tissue Engineering

    lead INDUSTRY

Principal Investigators

  • Luis M de la Fuente, MD · IADT, Buenos Aires, Argentina

  • Lech Cierpka, MD PhD · Department of General, Vascular and Transplant Surgery, Katowice, Poland

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-09-30
Primary Completion
2012-01-31
Completion
2012-12-31

Countries

  • Argentina
  • Poland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00850252 on ClinicalTrials.gov